In Brief Florida Cancer Specialists & Research Institute breaks ground for new location July 02, 2020Vol.46 No.27
Drugs & Targets Phesgo receives FDA approval in breast cancer indication for at home treatment July 02, 2020Vol.46 No.27
Drugs & Targets Keytruda receives FDA approval as first-line immunotherapy for MSI-H/dMMR MCC July 02, 2020Vol.46 No.27
Drugs & Targets Bavencio receives FDA approval for urothelial carcinoma maintenance treatment July 02, 2020Vol.46 No.27
Drugs & Targets Reblozyl approved by European Commission for transfusion-dependent anemia in adults with MDS or beta thalassemia July 02, 2020Vol.46 No.27
Drugs & Targets Guardant Health launches real-world clinical-genomic platform to accelerate precision oncology drug development July 02, 2020Vol.46 No.27
In Brief Frederic Pla named COO of The Parker Institute for Cancer Immunotherapy April 10, 2020Vol.46 No.15
In Brief Van Crocker Jr. named president and co-founder of CTCA Oncology Data, Analytics & Research Business April 10, 2020Vol.46 No.15
